Rajasansir Medical Limited - Accounts to registrar (filleted) - small 23.2.5

Rajasansir Medical Limited - Accounts to registrar (filleted) - small 23.2.5

RAJASANSIR MEDICAL LIMITED - Company Information

Print Friendly Version

IRIS Accounts Production v23.2.0.158 08071750 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false true false Ordinary Shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure080717502022-03-31080717502023-03-31080717502022-04-012023-03-31080717502021-03-31080717502021-04-012022-03-31080717502022-03-3108071750ns16:EnglandWales2022-04-012023-03-3108071750ns15:PoundSterling2022-04-012023-03-3108071750ns11:Director12022-04-012023-03-3108071750ns11:PrivateLimitedCompanyLtd2022-04-012023-03-3108071750ns11:SmallEntities2022-04-012023-03-3108071750ns11:AuditExempt-NoAccountantsReport2022-04-012023-03-3108071750ns11:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3108071750ns11:SmallCompaniesRegimeForAccounts2022-04-012023-03-3108071750ns11:FullAccounts2022-04-012023-03-3108071750ns11:OrdinaryShareClass12022-04-012023-03-3108071750ns11:Director22022-04-012023-03-3108071750ns11:CompanySecretary12022-04-012023-03-3108071750ns11:RegisteredOffice2022-04-012023-03-3108071750ns6:CurrentFinancialInstruments2023-03-3108071750ns6:CurrentFinancialInstruments2022-03-3108071750ns6:ShareCapital2023-03-3108071750ns6:ShareCapital2022-03-3108071750ns6:RetainedEarningsAccumulatedLosses2023-03-3108071750ns6:RetainedEarningsAccumulatedLosses2022-03-3108071750ns6:FurnitureFittings2022-04-012023-03-3108071750ns6:ComputerEquipment2022-04-012023-03-3108071750ns6:FurnitureFittings2022-03-3108071750ns6:ComputerEquipment2022-03-3108071750ns6:FurnitureFittings2023-03-3108071750ns6:ComputerEquipment2023-03-3108071750ns6:FurnitureFittings2022-03-3108071750ns6:ComputerEquipment2022-03-3108071750ns6:WithinOneYearns6:CurrentFinancialInstruments2023-03-3108071750ns6:WithinOneYearns6:CurrentFinancialInstruments2022-03-3108071750ns11:OrdinaryShareClass12023-03-31
REGISTERED NUMBER: 08071750 (England and Wales)










Financial Statements

for the Year Ended 31 March 2023

for

Rajasansir Medical Limited
SKS Bailey Group Limited
2 Heap Bridge
Bury
BL9 7HR








Rajasansir Medical Limited (Registered number: 08071750)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Rajasansir Medical Limited

Company Information
for the Year Ended 31 March 2023







DIRECTORS: K S Rajasansir
J G S Rajasansir





SECRETARY: J G S Rajasansir





REGISTERED OFFICE: 2 Heap Bridge
Heywood
Bury
BL9 7HR





REGISTERED NUMBER: 08071750 (England and Wales)





ACCOUNTANTS: SKS Bailey Group Limited
2 Heap Bridge
Bury
BL9 7HR
Page 1
Rajasansir Medical Limited (Registered number: 08071750)

Balance Sheet
31 March 2023

2023 2022
Notes £    £   
FIXED ASSETS
Tangible assets 3 197 884

CURRENT ASSETS
Debtors 4 5,094 4,871
Cash at bank 13,462 42,878
18,556 47,749
CREDITORS
Amounts falling due within one year 5 (18,646 ) (10,073 )
NET CURRENT (LIABILITIES)/ASSETS (90 ) 37,676
TOTAL ASSETS LESS CURRENT
LIABILITIES
107
38,560

CAPITAL AND RESERVES
Called up share capital 6 4 4
Retained earnings 103 38,556
SHAREHOLDERS' FUNDS 107 38,560

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 6 October 2023 and were signed on its behalf by:




J G S Rajasansir - Director


The notes form part of these financial statements

Page 2
Rajasansir Medical Limited (Registered number: 08071750)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TURNOVER
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 20% on reducing balance
Computer equipment - 50% on cost

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

2. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

Page 3 continued...
Rajasansir Medical Limited (Registered number: 08071750)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

3. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 April 2022
and 31 March 2023 1,000 10,223 11,223
DEPRECIATION
At 1 April 2022 893 9,446 10,339
Charge for year 21 666 687
At 31 March 2023 914 10,112 11,026
NET BOOK VALUE
At 31 March 2023 86 111 197
At 31 March 2022 107 777 884

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Other debtors 5,094 4,871

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 223 180
Corporation tax 524 1,097
VAT - 906
Directors' current accounts 16,660 6,659
Accrued expenses 1,239 1,231
18,646 10,073

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
4 Ordinary Shares 1 4 4

Page 4